This is the company’s second facility in the area, which will also be used for R&D.

PerkinElmer signed a long-term lease for an industrial/office research facility in Turku, Finland. It will reportedly serve as the headquarters for the company’s genetic screening business, which provides solutions for neonatal, clinical, and prenatal screening and diagnostics. A significant portion will also be used for R&D.


The transaction was facilitated through investment firm W. P. Carey & Co. CPA®:14, W. P. Carey & Co.’s publicly held nontraded REIT affiliate, acquired the Turku site for approximately 10 million. The facility is being leased to Wallac Oy, a subsidiary of PerkinElmer.


The acquisition is a follow-on transaction to an approximately 28 million sale-leaseback of an adjacent research and production building that CPA:14 completed with PerkinElmer in 2001. Both properties are located in Turku’s Bio Valley.

Previous articleUpstream Taps Lomonosov Moscow State University to Advance Tropical Parasitic Disease Research
Next articleScientists Discover Receptor’s Role in Colorectal Cancer